Pharmaceuticals, Biotechnology and Life Sciences
-With More than 1.9 Million Square Feet of Greenhouses, Clever Leaves is One of the Largest Cannabis Cultivation and Extraction…
Tilray has imported medical cannabis to USA and Canada in support of a new trieal, first-of-its-kind, which will test the…
GW Pharmaceuticals paved a way to launch Epidyolex in Europe, for use as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients 2 years of age and older.
Medical Marijuana, the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, record revenue of $20.7 million in the second quarter of 2019, a 30.8% increase over the same quarter in 2018.
Nexien BioPharma was granted patent for “Use of Cannabinoids and Terpenes for Treatment of Organophosphate and Carbamate Toxicity” by the Israeli Patent Office.
LONDON–(BUSINESS WIRE)–EMMAC Life Sciences Ltd, the European independent medical cannabis company, is pleased to announce that it has formed a…
Wize Pharma and Cannabics Pharmaceuticals have formed a joint venture (JV), to work on cannabinoid products to treat ophthalmic conditions, Wize said on Friday.
Tilray has imported medical cannabis oral solutions in bulk into the United Kingdom from its Good Manufacturing Practices (GMP)-certified facility in Canada.
EMMAC, the European independent medical cannabis company, is pleased to announce an exclusive collaboration with Hyris Ltd, a UK-based biotechnology company, to develop a comprehensive library of genetic profiles of existing cannabis varieties, and to industrialise DNA-based methods for the identification of its unique branded cultivars.
Columbia Care and Westmed testing precisely formulated cannabis-based drugs can relieve pain from arthritis